Human PD-L1/B7-H1 (Research Grade Durvalumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB10355SP	R&D Systems MAB10355SP	25 μg
MAB10355100	R&D Systems MAB10355100	100 μg

Description

PD-L1 Monoclonal specifically detects PD-L1 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: PD-L1
• Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 29126
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

• Clone: Hu125
• Applications: Flow Cytometry, CyTOF
• Conjugate: Unconjugated
• Host Species: Human
• Target Species: Human
• Gene Alias: Avelumab, B7-H, B7H1, B7-H1, B7H1PDCD1L1, CD274, CD274 antigenMGC142294, CD274 molecule, PDCD1L1, PDCD1LG1, PDCD1LG1MGC142296, PDL1, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1
• Immunogen: Human PD-L1/B7-H1,
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.